A case of extensive alopecia areata following Pfizer‐BioNTech BNT162b2 mRNA COVID‐19 vaccine with favorable outcome.

Autor: Matsuda, Yoshihiro, Kawakami, Yoshio, Kawamoto, Masaya, Hirai, Yoji, Morizane, Shin
Předmět:
Zdroj: Journal of Cutaneous Immunology & Allergy; Jun2023, Vol. 6 Issue 3, p115-116, 2p
Abstrakt: A 37‐year‐old woman developed persistent low‐grade fever (37.2°C) on day +13 after the first dose of BNT162b2 mRNA vaccine. She noticed coin‐sized hair loss on day +22, and it became widespread within 1 week. The patient's hair mostly recovered leaving only one oval bald patch on day +310 with topical corticosteroid therapy alone. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index